Integrated Care News by CFHA
APRIL 11, 2025
They can jeopardize not only our well-being but also that of others, as is the case with the alarming rise of vaccine hesitancy, which the World Health Organization declared a top global health threat in 2019—a stark reminder of the societal impact of false beliefs. Trust and truth go hand in hand.
FDA Law Blog
JUNE 7, 2021
Subpart H) pathway in 2014, then issued it as final guidance in January 2019. Valentine — Yesterday’s FDA approval of Biogen’s Alzheimer’s drug, Aduhelm (aducanumab-avwa), is historic and is of a magnitude that it may be harbinger for future Agency actions, especially in neuropsychiatric conditions. What do we mean?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Direct Doctors Difference
OCTOBER 21, 2021
In 2019 we discussed the basics of why patients wait a long time to hear back, get through on the phone lines, or be seen with a primary care doctor. Because the panel of patients at a typical PCP’s office is over 2000, and because doctors are still expected to see 20-30 patients a day, the wait times have only worsened since 2019.
BMJ
MAY 10, 2022
Introductory article to İkİIşik H, Sezerol MA, Taşçı Y, et alCOVID-19 vaccine hesitancy and related factors among primary healthcare workers in a district of Istanbul: a cross-sectional study from TurkeyFamily Medicine and Community Health 2022;10:e001430. 29% (n=86) of the participants were undecided about getting vaccinated.
Medical Xpress
JUNE 8, 2025
Sucrose is thought to activate centers of the brain that modulate pain and lead to the release of endorphins , but the exact mechanism remains unclear. It has become the worldwide standard of care for acute neonatal pain, but it doesnt seem to be helping in the long term. Read the original article.
FDA Law Blog
SEPTEMBER 30, 2024
Another rejected proposal was a definition of “vaccine” (vaccines are exempt from Medicaid rebates), which would have limited this term to a product that is administered prophylactically – i.e., to prevent rather than treat a disease. pricing, among other things. The most noteworthy are the following: 1. See 42 U.S.C.
FDA Law Blog
FEBRUARY 4, 2025
In the eleven years from 2009 to the end of 2019, FDA awarded 11 tropical disease PRVs for the development of therapies for diseases such as malaria, tuberculosis, dengue, and river blindness. Below, we discuss some of its downstream impacts on the PRV landscape. An Increased Interest in the Tropical Disease PRV Program? See Table 1.
Expert insights. Personalized for you.
130 
Let's personalize your content